Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lifevantage Corp | 438,571 | reported | 07 Apr 2009 | tx 5+354,307 |
| Vivos Therapeutics, Inc. | 180,533 | reported | 26 Nov 2024 | tx 11+766,534 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Nov 2024 | GRANT_AWARD | Vivos Therapeutics, Inc. | 149,533 | 2.64 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Vivos Therapeutics, Inc. | 15,000 | 2.38 USD | deriv |
| 23 Dec 2022 | GRANT_AWARD | Vivos Therapeutics, Inc. | 200,000 | 0.48 USD | deriv |
| 25 Feb 2022 | GRANT_AWARD | Vivos Therapeutics, Inc. | 50,000 | 3.27 USD | deriv |
| 31 Aug 2021 | GRANT_AWARD | Vivos Therapeutics, Inc. | 50,000 | 5.26 USD | deriv |
| 18 Nov 2019 | GRANT_AWARD | Vivos Therapeutics, Inc. | 16,667 | 7.50 USD | deriv |
| 22 Oct 2018 | GRANT_AWARD | Vivos Therapeutics, Inc. | 83,334 | 7.50 USD | deriv |
| 12 Mar 2021 | GRANT_AWARD | Vivos Therapeutics, Inc. | 100,000 | 7.50 USD | deriv |
| 25 May 2021 | PURCHASE | Vivos Therapeutics, Inc. | 1,000 | 5.29 USD | |
| 12 Mar 2021 | GRANT_AWARD | Vivos Therapeutics, Inc. | 100,000 | 7.50 USD | deriv |
| 24 Dec 2020 | PURCHASE | Vivos Therapeutics, Inc. | 1,000 | 7.38 USD | first after silence |
| 07 Apr 2009 | PURCHASE | Lifevantage Corp | 50,000 | 0.20 USD | |
| 07 Apr 2009 | PURCHASE | Lifevantage Corp | 50,000 | 0.50 USD | deriv |
| 27 Mar 2009 | GRANT_AWARD | Lifevantage Corp | 120,000 | 0.70 USD | deriv |
| 21 Feb 2008 | GRANT_AWARD | Lifevantage Corp | 14,307 | 0.35 USD | |
| 21 Feb 2008 | GRANT_AWARD | Lifevantage Corp | 120,000 | 0.35 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 24 Dec 2020.